Occurrence and risk assessment of pharmaceuticals and personal care products and endocrine disrupting chemicals in reclaimed water and receiving groundwater in China

Ecotoxicology and Environmental Safety

Volumn 119, Issue , 2015, Pages 74-80

  Li, Zhen ^a   Xiang, Xi ^a   Li, Miao ^a   Ma, Yeping ^a   Wang, Jihua ^b   Liu, Xiang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b HARBIN NORMAL UNIVERSITY   (China)

Author keywords

Endocrine disrupting compounds; Groundwater; Pharmaceuticals and personal care products; Reclaimed water; Risk assessment

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BEZAFIBRATE; CAFFEINE; CARBAMAZEPINE; CLOFIBRIC ACID; DRUG; ENDOCRINE DISRUPTOR; ESTRIOL; ETHINYLESTRADIOL; GROUND WATER; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; NALIDIXIC ACID; SULPIRIDE; BENZHYDRYL DERIVATIVE; COSMETIC; DRINKING WATER; PHENOL DERIVATIVE; WATER POLLUTANT;

DRUG; ENDOCRINE DISRUPTOR; GROUNDWATER POLLUTION; PHENOL; RISK ASSESSMENT; WATER QUALITY;

ARTICLE; BIOGEOGRAPHIC REGION; CONCENTRATION (PARAMETERS); HYGIENE PRODUCT; POLLUTION TRANSPORT; RISK ASSESSMENT; WATER CONTAMINATION; WATER QUALITY; WATER SAMPLING; ANALYSIS; CHEMISTRY; CHINA; CITY; ENVIRONMENTAL MONITORING; PROCEDURES; WATER POLLUTANT;

CHINA;

BENZHYDRYL COMPOUNDS; CHINA; CITIES; COSMETICS; DRINKING WATER; ENDOCRINE DISRUPTORS; ENVIRONMENTAL MONITORING; ETHINYL ESTRADIOL; GROUNDWATER; PHARMACEUTICAL PREPARATIONS; PHENOLS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

EID: 84929315449     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2015.04.031     Document Type: Article

References (54)

1. Al-Odaini N.A., et al. The occurrence of human pharmaceuticals in wastewater effluents and surface water of Langat River and its tributaries, Malaysia. Int. J. Environ. Anal. Chem. 2013, 93:245-264.
2. Banzhaf S., et al. Investigative approaches to determine exchange processes in the hyporheic zone of a low permeability riverbank. Hydrogeol. J. 2011, 19:591-601.
3. Barnes K.K., et al. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States - I. Groundwater. Sci. Total Environ. 2008, 402:192-200.
4. Behera S.K., et al. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 2011, 409:4351-4360.
5. Blackwell P.A., et al. The dissipation and transport of veterinary antibiotics in a sandy loam soil. Chemosphere 2007, 67:292-299.
6. Bu Q., et al. Pharmaceuticals and personal care products in the aquatic environment in China: a review. J. Hazard. Mater. 2013, 262:189-211.
7. Cabeza Y., et al. Monitoring the occurrence of emerging contaminants in treated wastewater and groundwater between 2008 and 2010.The Baix Llobregat (Barcelona, Spain). J. Hazard. Mater. 2012, 239:32-39.
8. Can Z.S., et al. Evaluation of different wastewater treatment techniques in three WWTPs in Istanbul for the removal of selected EDCs in liquid phase. Environ. Monit. Assess. 2014, 186:525-539.
9. Chang H., et al. determination and source apportionment of five classes of steroid hormones in urban rivers. Environ. Sci. Technol. 2009, 43:7691-7698.
10. Chen F., et al. Distribution and accumulation of endocrine-disrupting chemicals and pharmaceuticals in wastewater irrigated soils in Hebei, China. Environ. Pollut. 2011, 159:1490-1498.
11. Clara M., et al. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38:947-954.
12. Damasio J., et al. Are pharmaceuticals more harmful than other pollutants to aquatic invertebrate species: a hypothesis tested using multi-biomarker and multi-species responses in field collected and transplanted organisms. Chemosphere 2011, 85:1548-1554.
13. Drillia P., et al. Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 2005, 60:1034-1044.
14. Estevez E., et al. Screening of emerging contaminants and priority substances (2008/105/EC) in reclaimed water for irrigation and groundwater in a volcanic aquifer (Gran Canaria, Canary Islands, Spain). Sci. Total Environ. 2012, 433:538-546.
15. Ferrari B., et al. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 2004, 23:1344-1354.
16. Ginebreda A., et al. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ. Int. 2010, 36:153-162.
17. Gros M., et al. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
18. Guerra P., et al. Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci. Total Environ. 2014, 473:235-243.
19. Guo Y., et al. National survey of urban sewage reuse in China. Huanjing Kexue 2012, 33:3881-3884.
20. He Y., et al. Fate and removal of typical pharmaceuticals and personal care products by three different treatment processes. Sci. Total Environ. 2013, 447:248-254.
21. Karnjanapiboonwong A., et al. Occurrence of PPCPs at a wastewater treatment plant and in soil and groundwater at a land application site. Water Air Soil Pollut. 2011, 216:257-273.
22. Kasprzyk-Hordern B., et al. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43:363-380.
23. Kosma C.I., et al. Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466:421-438.
24. Kuch B., et al. Effect-related monitoring: estrogen-like substances in groundwater. Environ. Sci. Pollut. Res. 2010, 17:250-260.
25. Kuroda K., et al. Assessment of groundwater pollution in Tokyo using PPCPs as sewage markers. Environ. Sci. Technol. 2012, 46:1455-1464.
26. Kuroda K., et al. Assessment of groundwater pollution in Tokyo using PPCPs as sewage markers. Environ. Sci. Technol. 2012, 46:1455-1464.
27. Kwon J., Rodriguez J.M. Occurrence and removal of selected pharmaceuticals and personal care products in three wastewater-treatment plants. Arch. Environ. Contam. Toxicol. 2014, 66:538-548.
28. Lapworth D.J., et al. Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ. Poll. 2012, 163:287-303.
29. Li J.Z., et al. Adsorption and aerobic biodegradation of four selected endocrine disrupting chemicals in soil-water system. Int. Biodeterior. Biodegrad. 2013, 76:3-7.
30. Li J.Z., et al. Spatial and seasonal variations of occurrences and concentrations of endocrine disrupting chemicals in unconfined and confined aquifers recharged by reclaimed water: a field study along the Chaobai River,Beijing. Sci. Total Environ. 2013, 450:162-168.
31. Li X., et al. Occurrence and removal of pharmaceutical and hormone contaminants in rural wastewater treatment lagoons. Sci. Total Environ. 2013, 445:22-28.
32. Loffler D., et al. Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol. 2005, 39:5209-5218.
33. Nanjappa M.K., et al. Bisphenol A regulation of testicular endocrine function in male rats is affected by diet. Toxicol. Lett. 2014, 225:479-487.
34. Ngoc H.T., et al. Simultaneous determination of PPCPs, EDCs, and artificial sweeteners in environmental water samples using a single-step SPE coupled With HPLC-MS/MS and isotope dilution. Talanta 2013, 113:82-92.
35. Ngoc H.T., et al. Occurrence and suitability of pharmaceuticals and personal care products as molecular markers for raw wastewater contamination in surface water and groundwater. Environ. Sci. Pollut. Res. 2014, 21:4727-4740.
36. Ogunseitan O.A. Removal of caffeine in sewage by Pseudomonas putida: Implications for water pollution index. World J. Microb. Biotechnol. 1996, 12:251-256.
37. Padhye L.P., et al. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant. Water Res. 2014, 51:266-276.
38. Reyes-Contreras C., et al. Evaluation of PPCPs removal in a combined anaerobic digester-constructed wetland pilot plant treating urban wastewater. Chemosphere 2011, 84:1200-1207.
39. Santos J.L., et al. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ. Int. 2007, 33:596-601.
40. Santos J.L., et al. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ. Int. 2007, 33:596-601.
41. Stuart M.E., et al. Fingerprinting groundwater pollution in catchments with contrasting contaminant sources using microorganic compounds. Sci. Total Environ. 2014, 468:564-577.
42. Stuart M.E., et al. Fingerprinting groundwater pollution in catchments with contrasting contaminant sources using microorganic compounds. Sci. Total Environ. 2014, 468:564-577.
43. Sui Q., et al. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ. Sci. Technol. 2011, 45:3341-3348.
44. Sun Q.F., et al. Contributors to estrogenic activity in wastewater from a large wastewater treatment plant in Beijing, China. Environ. Toxicol. Pharmacol. 2008, 25:20-26.
45. Sun Y., et al. Occurrence of estrogenic endocrine disrupting chemicals concern in sewage plant effluent. Front. Environ. Sci. Eng. 2014, 8:18-26.
46. Teijon G., et al. Occurrence of emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci. Total Environ. 2010, 408:3584-3595.
47. Tolls J. Sorption of veterinary pharmaceuticals in soils: a review. Environ. Sci. Technol. 2001, 35:3397-3406.
48. Tran N.H., et al. A preliminary study on the occurrence of pharmaceutically active compounds in hospital wastewater and surface water in Hanoi, Vietnam. Clean-Soil Air Water 2014, 42:267-275.
49. US Environmental Protection Agency (USEPA), 2012.
50. Wang D., et al. Occurrence and removal of six pharmaceuticals and personal care products in a wastewater treatment plant employing anaerobic/anoxic/aerobic and UV processes in Shanghai, China. Environ. Sci. Pollut. Res. 2014, 21:4276-4285.
51. Wu Y., et al. Adsorption of diethyl phthalate ester to clay minerals. Chemosphere 2015, 119:690-696.
52. Young T.A., et al. Ab initio and in situ comparison of caffeine, triclosan, and triclocarban as indicators of sewage-derived microbes in surface waters. Environ. Sci. Technol. 2008, 42:3335-3340.
53. Yuan S.L., et al. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 2013, 90:2520-2525.
54. Zheng, F., et al., 2015. Effects of Reclaimed Water Use for Scenic Water on Groundwater Environment in a Multilayered Aquifer System Beneath the Chaobai River,Beijing, China: Case Study, vol. 20.